BMS POETYK 1 PPLS Video EB03_VR2.mp4 (42.09 MB)

Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-1 study): a plain language summary - supplementary video

media

posted on 2023-05-30, 07:34 authored by April W Armstrong, Melinda Gooderham, Richard B Warren, Kim A Papp, Bruce Strober, Diamant Thaçi, Akimichi Morita, Jacek C Szepietowski, Shinichi Imafuku, Elizabeth Colston, John Throup, Sudeep Kundu, Steve Schoenfeld, Misti Linaberry, Subhashis Banerjee, Andrew Blauvelt

Supplementary video

Funding

A full list of disclosures of the authors can be found at the end of the original article at: https://doi.org/10.1016/j.jaad.2022.07.002

History

Usage metrics

Keywords

Psoriasis Deucravacitinib Apremilast Enzyme Placebo Plaque POETYK Tyrosine kinase TYK-2 Dermatology Phosphodiesterase

Licence

CC BY-NC-ND 4.0

Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-1 study): a plain language summary - supplementary video

Funding

A full list of disclosures of the authors can be found at the end of the original article at: https://doi.org/10.1016/j.jaad.2022.07.002

History

Usage metrics

Categories

Keywords

Licence

Exports

Treatment of plaque psoriasis with ­deucravacitinib (POETYK PSO-1 study): a plain language summary - supplementary video

Funding

A full list of disclosures of the authors can be found at the end of the original article at: https://doi.org/10.1016/j.jaad.2022.07.002

History

Usage metrics

Categories

Keywords

Licence

Exports

Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-1 study): a plain language summary - supplementary video